MediaTek launches entry-level Helio gaming chipsets
by Maria Thomas
Updated Jun 30, 2020
Both chips are powered by Arm Cortex-A53 CPUs and aims to provide fast-gaming experiences.
The chips feature IMG PowerVR GE8320 GPUs, with speed up to 650MHz and up to 680 MHz for the MediaTek Helio G25 and G35, respectively, the company said in a statement.
Both Helio G25 and G35 have optimal power efficiency due to an advanced 12nm FinFET production process which, combined with MediaTek HyperEngine's intelligent power management, ensures long battery-life and power efficiency, even during long gaming sessions.
The chips feature an enhanced MediaTek HyperEngine, for intelligent resource management that ensures sustained and smooth performance, even in demanding action.
When theWi-Fi signal is weak, the technology intelligently triggers Wi-Fi and LTE concurrency within milliseconds, to ensure a lag-free connection.
MediaTek HyperEngine also lets users defer calls, while in a game, so you never drop a connection or have to stop your game-play.
In terms of cameras, both the chipsets support multi-camera setup and include a hardware depth engine for dual-camera bokeh photography.
The G25 supports a single camera mode of up to 21MP at 30fps, while the G35 supports up to 25MP cameras and AI-enhanced camera features including simulated bokeh effects.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report